- Home
- TSAT vs BDSX Comparison
TSAT vs BDSX Comparison
Compare TSAT & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSAT
- BDSX
- Stock Information
- Founded
- TSAT 1969
- BDSX 2005
- Country
- TSAT Canada
- BDSX United States
- Employees
- TSAT N/A
- BDSX N/A
- Industry
- TSAT Metal Fabrications
- BDSX Precision Instruments
- Sector
- TSAT Industrials
- BDSX Health Care
- Exchange
- TSAT Nasdaq
- BDSX Nasdaq
- Market Cap
- TSAT 236.1M
- BDSX 194.9M
- IPO Year
- TSAT 1996
- BDSX 2020
- Fundamental
- Price
- TSAT $17.18
- BDSX $1.51
- Analyst Decision
- TSAT Hold
- BDSX Strong Buy
- Analyst Count
- TSAT 1
- BDSX 4
- Target Price
- TSAT $9.00
- BDSX $3.08
- AVG Volume (30 Days)
- TSAT 84.9K
- BDSX 332.5K
- Earning Date
- TSAT 11-14-2024
- BDSX 11-01-2024
- Dividend Yield
- TSAT N/A
- BDSX N/A
- EPS Growth
- TSAT N/A
- BDSX N/A
- EPS
- TSAT 2.55
- BDSX N/A
- Revenue
- TSAT $450,756,875.00
- BDSX $65,562,000.00
- Revenue This Year
- TSAT N/A
- BDSX $46.97
- Revenue Next Year
- TSAT N/A
- BDSX $30.43
- P/E Ratio
- TSAT $6.61
- BDSX N/A
- Revenue Growth
- TSAT N/A
- BDSX 48.92
- 52 Week Low
- TSAT $6.93
- BDSX $1.11
- 52 Week High
- TSAT $18.80
- BDSX $2.21
- Technical
- Relative Strength Index (RSI)
- TSAT 60.44
- BDSX 48.94
- Support Level
- TSAT $16.13
- BDSX $1.24
- Resistance Level
- TSAT $18.80
- BDSX $1.43
- Average True Range (ATR)
- TSAT 1.40
- BDSX 0.10
- MACD
- TSAT 0.12
- BDSX 0.01
- Stochastic Oscillator
- TSAT 63.58
- BDSX 64.44
About TSAT Telesat Corporation and Class B Variable Voting Shares
Telesat Corp is a global satellite operator, that provides its customers with mission-critical communications services. It operates in a single operating segment, in which it provides satellite-based services to its broadcast, enterprise, and consulting customers around the world. Geographically, it derives a majority of its revenue from Canada. It derives revenue from Broadcast, Enterprise, Consulting, and others.
About BDSX Biodesix Inc.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.